- Home
- INBX vs CIA Comparison
INBX vs CIA Comparison
Compare INBX & CIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INBX
- CIA
- Stock Information
- Founded
- INBX 2010
- CIA 1969
- Country
- INBX United States
- CIA United States
- Employees
- INBX N/A
- CIA N/A
- Industry
- INBX Biotechnology: Pharmaceutical Preparations
- CIA Life Insurance
- Sector
- INBX Health Care
- CIA Finance
- Exchange
- INBX Nasdaq
- CIA Nasdaq
- Market Cap
- INBX 222.5M
- CIA 222.9M
- IPO Year
- INBX 2020
- CIA N/A
- Fundamental
- Price
- INBX $13.98
- CIA $4.80
- Analyst Decision
- INBX Hold
- CIA
- Analyst Count
- INBX 1
- CIA 0
- Target Price
- INBX N/A
- CIA N/A
- AVG Volume (30 Days)
- INBX 70.4K
- CIA 97.6K
- Earning Date
- INBX 11-14-2024
- CIA 11-07-2024
- Dividend Yield
- INBX N/A
- CIA N/A
- EPS Growth
- INBX N/A
- CIA N/A
- EPS
- INBX 119.38
- CIA 0.43
- Revenue
- INBX $1,568,000.00
- CIA $248,376,000.00
- Revenue This Year
- INBX N/A
- CIA N/A
- Revenue Next Year
- INBX N/A
- CIA $4.17
- P/E Ratio
- INBX $0.12
- CIA $11.10
- Revenue Growth
- INBX 19.24
- CIA 3.02
- 52 Week Low
- INBX $10.80
- CIA $1.78
- 52 Week High
- INBX $18.95
- CIA $5.95
- Technical
- Relative Strength Index (RSI)
- INBX 37.51
- CIA 54.87
- Support Level
- INBX $13.27
- CIA $4.34
- Resistance Level
- INBX $14.49
- CIA $4.85
- Average True Range (ATR)
- INBX 1.00
- CIA 0.26
- MACD
- INBX -0.23
- CIA -0.03
- Stochastic Oscillator
- INBX 33.53
- CIA 51.49
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
About CIA Citizens Inc. ($1.00 Par)
Citizens Inc is an insurance holding company serving the life insurance needs of individuals in the United States. The company provides insurance benefits to residents in thirty two U.S. states and more than seventy countries through its insurance subsidiaries. the Company derives its revenues principally from life insurance premiums earned for insurance coverages provided to insureds in our two operating segments and net investment income. The company operates in two business segments namely the Life Insurance segment and the Home Service Insurance segment. The company majority generates revenues from Life Insurance segment.